Core Viewpoint - The CEO of New Oxygen Group, Jin Xing, stated that the friction with upstream suppliers has not significantly impacted the company's business, despite some suppliers expressing concerns about the company's pricing strategy and product sourcing [1][2][6]. Group 1: Pricing Strategy and Market Impact - In September 2025, New Oxygen launched the "Youth Needle" product priced at 2999 yuan, which is significantly lower than the market price of over 10,000 yuan, disrupting the existing pricing structure of upstream manufacturers [1][6]. - Despite backlash from several upstream manufacturers, including claims of unauthorized product sourcing and training issues, sales of the "Youth Needle" reportedly surged in October, November, and December 2025, indicating strong consumer acceptance [2][6][7]. Group 2: Business Expansion and Partnerships - As of January 8, 2026, New Oxygen has established 50 clinics across 16 cities and achieved a cumulative treatment volume of 1 million [3][6]. - New Oxygen announced the formation of the "Youth Premium Alliance" with 14 upstream manufacturers, aiming to enhance collaboration through price-volume linkage, tiered supply, training, and product traceability [3][6]. Group 3: Industry Dynamics and Future Outlook - The medical beauty industry is experiencing a shift towards a buyer's market, with an increasing number of suppliers providing more options for medical institutions, which can now select long-term partners and customize products based on their needs [4][7]. - The industry has seen a significant increase in the issuance of medical device certifications, with 52 Class III medical device certificates issued in 2025, suggesting a growing supply landscape [4][7].

Core Viewpoint - The stock price of Pop Mart has dropped over 40% since reaching a peak of HKD 339.80 per share on August 26, 2022, primarily due to the decline in the premium of its phenomenon and IP LABUBU [1][3]. Group 1: Stock Performance and Market Sentiment - Pop Mart's stock has seen a significant decline, with the average transaction price of a single LABUBU blind box dropping by 23% compared to its highest price in the last 90 days [1]. - The number of short-sold shares of Pop Mart has sharply increased, nearing 10,000 shares since August 2025, indicating market anxiety [3]. - Following a share buyback announcement, Pop Mart's stock price increased by 7.96% since January 19, 2026, when the buyback was announced [12]. Group 2: Company Strategy and Product Management - Pop Mart has initiated a share buyback of 1.4 million shares for HKD 2.51 billion, signaling management's confidence to investors [3]. - The company has actively worked to combat scalpers and increase product availability, with LABUBU's sales potentially reaching 10 million units monthly [6]. - Pop Mart has successfully regained pricing power, allowing consumers to purchase regular products at near official prices while maintaining the scarcity of limited editions [6]. Group 3: Financial Performance and Future Outlook - LABUBU's revenue in the first half of 2025 reached CNY 4.81 billion, accounting for nearly one-third of Pop Mart's total revenue [5]. - Deutsche Bank reported that LABUBU's production capacity increased from 10 million units in the first half of 2025 to an average of 50 million units per month by the end of the year, potentially generating an adjusted net profit of approximately CNY 14.5 billion in 2025 [7]. - Analysts predict that Pop Mart's net profit will reach CNY 12.6 billion in 2025, supported by the recent share buyback [11].